홈 › 방광암 › 노스캐롤라이나

노스캐롤라이나의 방광암 임상 시험

방광암 관련 연구 26개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Margaret R Pardee Memorial Hospital, Hendersonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03866382

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

WakeMed Raleigh Campus ( Site 0811), Raleigh

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07419295

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06770582

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Biorepository and Precision Pathology Center (BRPC), Durham
Duke Cancer Institute, Durham
Substrate Services Core Research Support (SSCRS), Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07206225

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
외 6개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of North Carolina (UNC) - Chapel Hill, Chapel Hill

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Duke Cancer Center Cary, Cary
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07097142

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

University of North Carolina, Chapel Hill

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07225127

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Duke Cancer Center Cary, Cary
Duke University Medical Center (location of scans), Durham
Duke University Medical Center - Duke University Hospital (location of scans), Durham
외 5개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Levine Cancer Institute, Charlotte
Oncology Specialists of Charlotte, Charlotte
Wake Forest Baptist Health, Winston-Salem

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT07218380

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

피험자 모집 중관찰 연구

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Duke University Medical Center - Duke Cancer Center, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

University of North Carolina, Chapel Hill
Atrium Health/Levine Center, Charlotte
Associated Urologist of North Carolina (Solaris), Raleigh

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Chapel Hill

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07129993

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

UNC Chapel Hill Hospital, Chapel Hill
Duke Health - Duke Cancer Center, Durham
Associated Urologists of North Carolina, Raleigh

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT04752722

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem

피험자 모집 중2상

8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill
Carolinas Medical Center (biopsy only), Charlotte
외 10개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04879329